|
4NU1
Crystal structure of a transition state mimic of the GSK-3/Axin complex bound to phosphorylated N-terminal auto-inhibitory pS9 peptide
Deposited 2013-12-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–383(383 aa)
Fragment:Residues 1-383 with phosphoylated Ser9
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 2
MG MAGNESIUM ION × 2
ADP ADENOSINE-5'-DIPHOSPHATE × 1
AF3 ALUMINUM FLUORIDE × 1
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;277 K;10% PEG 35,000, 20mM Tris pH7.5, 300mM NaCl, 5% glycerol, 10mM MgCl2, 200uM ATP, and 5mM DTT, MICRODIALYSIS, temperature 277K
|
Resolution 2.50 Å
R-free 0.245
|
|
5AIR
Structural analysis of mouse GSK3beta fused with LRP6 peptide.
Deposited 2015-02-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
4–420(417 aa)
Fragment:;RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420
;
Chain B
4–420(417 aa)
Fragment:;RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420,RESIDUES 1565-1574, KINASE DOMAIN, RESIDUES 6-420
;
|
Not recorded
|
MLI MALONATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;290 K;200 MM SODIUM MALONATE, 20 % (V/V) PEG 3350, pH 7
|
Resolution 2.53 Å
R-free 0.260
|
|
8VME
Crystal structure of the GSK-3/Axin complex bound to a phosphorylated beta-catenin T41A peptide
Deposited 2024-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
26–383(358 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 2
GOL GLYCEROL × 6
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;277 K;10% PEG35000, 20 mM Tris, pH 7.5, 300 mM sodium chloride, 5% glycerol, 10 mM magnesium chloride, 200 uM ATP, 5 mM DTT
|
Resolution 2.30 Å
R-free 0.230
|
|
8VMF
Crystal structure of a transition-state mimic of the GSK-3/Axin complex bound to a beta-catenin S45D peptide
Deposited 2024-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
26–383(358 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
AF3 ALUMINUM FLUORIDE × 1
ADP ADENOSINE-5'-DIPHOSPHATE × 1
GOL GLYCEROL × 3
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;pH 7.5;277 K;10% PEG35000, 20 mM Tris, pH 7.5, 300 mM sodium chloride, 5% glycerol, 10 mM magnesium chloride, 5 mM DTT, 200 uM ADP, 200 uM aluminum nitrate, 1.2 mM sodium fluoride
|
Resolution 2.50 Å
R-free 0.251
|
|
8VMG
Crystal structure of GSK-3 26-383 bound to Axin 383-435
Deposited 2024-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
26–383(358 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
EDO 1,2-ETHANEDIOL × 20
NO3 NITRATE ION × 8
GOL GLYCEROL × 4
SO4 SULFATE ION × 7
MG MAGNESIUM ION × 1
CL CHLORIDE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;100 mM MES, pH 5.5, 1.9 M ammonium sulfate, 200 mM sodium chloride, cryoprotectant: 25% ethylene glycol
|
Resolution 2.45 Å
R-free 0.230
|
|
8VMG
Crystal structure of GSK-3 26-383 bound to Axin 383-435
Deposited 2024-01-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
26–383(358 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 19
SO4 SULFATE ION × 2
CL CHLORIDE ION × 8
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;100 mM MES, pH 5.5, 1.9 M ammonium sulfate, 200 mM sodium chloride, cryoprotectant: 25% ethylene glycol
|
Resolution 2.45 Å
R-free 0.230
|